rel-(2R,3S,4R,5S)-Hexane-1,2,3,4,5,6-hexaol

Catalog No. :
ACTZEW405
CAS No. :
608-66-2
Molecular Formula :
C6H14O6
Molecular Weight :
182.17

IUPAC Name:(2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexaol

rel-(2R,3S,4R,5S)-Hexane-1,2,3,4,5,6-hexaol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$97.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(2R,3S,4R,5S)-Hexane-1,2,3,4,5,6-hexaol
IUPAC Name(2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexaol
MDL No.MFCD00064288
Molecular FormulaC6H14O6
Molecular Weight182.17
SMILESOC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)CO
InChI KeyFBPFZTCFMRRESA-GUCUJZIJSA-N
Synonymdulcitol | galactitol | 608-66-2 | dulcite | Euonymit | D-Galactitol | dulcose | Melampyrin | Melampyrit | (2R,3S,4R,5S)-Hexane-1,2,3,4,5,6-hexaol | D-Dulcitol | (2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol | Melampyrite | Melampyrum | meso-galactitol | L-galactitol | CHEBI:16813 | NSC 1944 | 113
CAS No.608-66-2
PubChem CID11850

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACTZEW405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACERUQ452 route compound structure diagram
    ACERUQ452867-55-0 In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Then
  5. ACTZEW405 route product structure diagram
    ACTZEW405608-66-2 In Stock
Inquiry

2. ACTZEW405 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWFXE850 route compound structure diagram
    ACWFXE85087-99-0 In Stock
  2. Plus
  3. ACVDFI809 route compound structure diagram
    ACVDFI80987-89-8 In Stock
  4. Then
  5. ACTZEW405 route product structure diagram
    ACTZEW405608-66-2 In Stock
Inquiry

Comments (0)